First Time Loading...

AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 10 716 GBX -0.24% Market Closed
Updated: Mar 28, 2024

AstraZeneca PLC
Operating Income

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

AstraZeneca PLC
Operating Income Peer Comparison

Comparables:
GSK
VRNA
INDV
HIK
DPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Operating Income
$8.9B
CAGR 3-Years
27%
CAGR 5-Years
30%
CAGR 10-Years
9%
GlaxoSmithKline PLC
LSE:GSK
Operating Income
£8.3B
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
2%
Verona Pharma PLC
NASDAQ:VRNA
Operating Income
$-67.6m
CAGR 3-Years
3%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Operating Income
$270m
CAGR 3-Years
45%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$710m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
7%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
£24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%

See Also

What is AstraZeneca PLC's Operating Income?
Operating Income
8.9B USD

Based on the financial report for Dec 31, 2023, AstraZeneca PLC's Operating Income amounts to 8.9B USD.

What is AstraZeneca PLC's Operating Income growth rate?
Operating Income CAGR 10Y
9%

Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for AstraZeneca PLC have been 27% over the past three years , 30% over the past five years , and 9% over the past ten years .